{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["ALI", "ARDS", "COVID-19", "Oxidative stress", "Ozone (O3) the", "Pneumonia"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "33476982", "DateCompleted": {"Year": "2021", "Month": "02", "Day": "22"}, "DateRevised": {"Year": "2023", "Month": "01", "Day": "24"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2020", "Month": "12", "Day": "21"}], "ELocationID": ["10.1016/j.intimp.2020.107307", "S1567-5769(20)33774-7"], "Journal": {"ISSN": "1878-1705", "JournalIssue": {"Volume": "92", "PubDate": {"Year": "2021", "Month": "Mar"}}, "Title": "International immunopharmacology", "ISOAbbreviation": "Int Immunopharmacol"}, "ArticleTitle": "Ozone therapy for the treatment of COVID-19 pneumonia: A scoping review.", "Pagination": {"StartPage": "107307", "MedlinePgn": "107307"}, "Abstract": {"AbstractText": ["Severe forms of COVID-19 can evolve into pneumonia, featured by acute respiratory failure due to acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). In viral diseases, the replication of viruses is seemingly stimulated by an imbalance between pro-oxidant and antioxidant activity as well as by the deprivation of antioxidant mechanisms. In COVID-19 pneumonia, oxidative stress also appears to be highly detrimental to lung tissues. Although inhaling ozone (O3) gas has been shown to be toxic to the lungs, recent evidence suggests that its administration via appropriate routes and at small doses can paradoxically induce an adaptive reaction capable of decreasing the endogenous oxidative stress. Ozone therapy is recommended to counter the disruptive effects of severe COVID-19 on lung tissues, especially if administered in early stages of the disease, thereby preventing the progression to ARDS."], "CopyrightInformation": "Copyright \u00a9 2020 Elsevier B.V. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Health Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran."}], "LastName": "Izadi", "ForeName": "Morteza", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Local Health Unit N. 2 \"Marca Trevigiana\", Public Health Department, Treviso, Italy."}], "LastName": "Cegolon", "ForeName": "Luca", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran. Electronic address: mhmjvbt81@gmail.com."}], "LastName": "Javanbakht", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Health Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran. Electronic address: Ali_sh_1993@yahoo.com."}], "LastName": "Sarafzadeh", "ForeName": "Ali", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pediatric Congenital Hematologic Disorders Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran."}], "LastName": "Abolghasemi", "ForeName": "Hassan", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran."}], "LastName": "Alishiri", "ForeName": "Gholamhossein", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "JC School of Public Health and Primary Care, Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Zhao", "ForeName": "Shi", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran."}], "LastName": "Einollahi", "ForeName": "Behzad", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shahid Akbarabadi Clinical Research Development, Unit (ShACRDU), Iran University of Medical Sciences (IUMS), Tehran, Iran."}], "LastName": "Kashaki", "ForeName": "Mandana", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Health Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran."}], "LastName": "Jonaidi-Jafari", "ForeName": "Nematollah", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran."}], "LastName": "Asadi", "ForeName": "Mosa", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Radiology, Baqiyatallah University of Medical Sciences, Tehran, Iran."}], "LastName": "Jafari", "ForeName": "Ramezan", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Fellowship, Tehran University, Tehran, Iran."}], "LastName": "Fathi", "ForeName": "Saeid", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran."}], "LastName": "Nikoueinejad", "ForeName": "Hassan", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran."}], "LastName": "Ebrahimi", "ForeName": "Mehrdad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Student Research Committee (SRC), Baqiyatallah University of Medical Sciences, Tehran, Iran."}], "LastName": "Imanizadeh", "ForeName": "Sina", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Student Research Committee (SRC), Baqiyatallah University of Medical Sciences, Tehran, Iran."}], "LastName": "Ghazale", "ForeName": "Amir Hosein", "Initials": "AH"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Int Immunopharmacol", "NlmUniqueID": "100965259", "ISSNLinking": "1567-5769"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Oxidants, Photochemical"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": ["therapy"], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Oxidants, Photochemical"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}], "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Sharma A., Tiwari S., Deb M.K., Marty J.L. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies. Int. J. Antimicrob. Agents. 2020;56(2)", "ArticleIdList": ["PMC7286265", "32534188"]}, {"Citation": "Chauhan S. Comprehensive review of coronavirus disease 2019 (COVID-19) Biomed. J. 2020;43(4):334\u2013340.", "ArticleIdList": ["PMC7263230", "32788071"]}, {"Citation": "Acter T., Uddin N., Das J., Akhter A., Choudhury T.R., Kim S. Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency. Sci. Total Environ. 2020;730 doi: 10.1016/j.scitotenv.2020.138996.", "ArticleIdList": ["10.1016/j.scitotenv.2020.138996", "PMC7190497", "32371230"]}, {"Citation": "Zhong N.S., Zheng B.J., Li Y.M., et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China. Lancet. 2003;362(9393):1353\u20131358.", "ArticleIdList": ["PMC7112415", "14585636"]}, {"Citation": "Drosten C., G\u00fcnther S., Preiser W., et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 2003;348(20):1967\u20131976.", "ArticleIdList": ["12690091"]}, {"Citation": "A. Pavli, S. Tsiodras, H.C. Maltezou, Middle East respiratory syndrome coronavirus (MERS-CoV): prevention in travelers, Travel Med. Infect. Dis. 2014;12(6 Pt A):602\u2013608.", "ArticleIdList": ["PMC7110598", "25457301"]}, {"Citation": "Ren L.-L., Wang Y.-M., Wu Z.-Q., et al. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin. Med. J. (Engl.) 2020;133(9):1015\u20131024.", "ArticleIdList": ["PMC7147275", "32004165"]}, {"Citation": "Yanes-Lane M., Winters N., Fregonese F., Bastos M., Perlman-Arrow S., Campbell J.R., Menzies D. Proportion of asymptomatic infection among COVID-19 positive persons and their transmission potential: A systematic review and meta-analysis. PLoS ONE. 2020;15(11)", "ArticleIdList": ["PMC7608887", "33141862"]}, {"Citation": "Cegolon L., Pichierri J., Mastrangelo G., Cinquetti S., Sotgiu G., Bellizzi S., Pichierri G. Hypothesis to explain the severe form of COVID-19 in Northern Italy. BMJ Glob. Health. 2020;5(6)", "ArticleIdList": ["PMC7295427", "32532758"]}, {"Citation": "Cegolon L., Javanbakht M., Mastrangelo G. Nasal disinfection for the prevention and control of COVID-19: A scoping review on potential chemo-preventive agents. Int. J. Hyg. Environ. Health. 2020;230", "ArticleIdList": ["PMC7434367", "32898838"]}, {"Citation": "Wu Z., McGoogan J.M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239\u20131242.", "ArticleIdList": ["32091533"]}, {"Citation": "Richardson S., Hirsch J.S., Narasimhan M., et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052\u20132059.", "ArticleIdList": ["PMC7177629", "32320003"]}, {"Citation": "World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV). Available from: https://www.who.int/health-topics/middle-east-respiratory-syndrome-coronavirus-mers#tab=tab_1 (last accessed on 18th November 2020)."}, {"Citation": "Cegolon L. Investigating hypothiocyanite against SARS-CoV-2. Int. J. Hyg. Environ. Health. 2020 Jun;227", "ArticleIdList": ["PMC7135769", "32305009"]}, {"Citation": "Kim PS, Read SW, Fauci AS. Therapy for Early COVID-19: A Critical Need. JAMA. 2020 Nov 11. doi: 10.1001/jama.2020.22813. Epub ahead of print.", "ArticleIdList": ["33175121"]}, {"Citation": "Gavazza A., Marchegiani A., Rossi G., Franzini M., Spaterna A., Mangiaterra S., Cerquetella M. Ozone Therapy as a Possible Option in COVID-19 Management. Front. Public Health. 2020;8:417.", "ArticleIdList": ["PMC7477102", "32984235"]}, {"Citation": "Hudson J.B., Sharma M., Vimalanathan S. Development of a practical method for using ozone gas as a virus decontaminating agent. Ozone Sci. Eng. 2009;31:216\u2013223."}, {"Citation": "Tseng C., Li C. Inactivation of surface viruses by gaseous ozone. J. Environ. Health. 2008;70:56\u201363.", "ArticleIdList": ["18561570"]}, {"Citation": "Li C.S., Wang Y.C. Surface germicidal effects of ozone for microorganisms. AIHA J. 2003;64:533\u2013537.", "ArticleIdList": ["12908871"]}, {"Citation": "Zhou M. Ozone: a powerful weapon to combat COVID-19 out-break. 2020. http://www.china.org.cn/opinion/2020-02/26/con-tent_75747237_4.htm (last accessed on 20th November 2020)."}, {"Citation": "Rowen R.J., Robins H. A plausible \u201cpenny\u201d costing effective treatment for corona virus - ozone therapy. J. Infect. Dis. Epidemiol. 2020;6:113."}, {"Citation": "Hern\u00e1ndez A., Papadakos P.J., Torres A., Gonz\u00e1lez D.A., Vives M., Ferrando C., Baeza J. Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19. Rev. Esp. Anestesiol. Reanim. 2020;67(5):245\u2013252.", "ArticleIdList": ["PMC7156242", "32303365"]}, {"Citation": "Khomich O.A., Kochetkov S.N., Bartosch B., Ivanov A.V. Redox Biology of Respiratory Viral Infections. Viruses. 2018 Jul 26;10(8):392.", "ArticleIdList": ["PMC6115776", "30049972"]}, {"Citation": "Van den Brand J.M., Haagmans B.L., van Riel D., Osterhaus A.D., Kuiken T. The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models. J. Comp. Pathol. 2014;151(1):83\u2013112.", "ArticleIdList": ["PMC7094469", "24581932"]}, {"Citation": "Mantzarlis K., Tsolaki V., Zakynthinos E. Role of Oxidative Stress and Mitochondrial Dysfunction in Sepsis and Potential Therapies. Oxid. Med. Cell Longev. 2017;2017:5985209.", "ArticleIdList": ["PMC5585571", "28904739"]}, {"Citation": "Fink M.P. Bench-to-bedside review: Cytopathic hypoxia. Crit. Care. 2002;6(6):491\u2013499.", "ArticleIdList": ["PMC153437", "12493070"]}, {"Citation": "Takeda K., Shimada Y., Amano M., Sakai T., Okada T., Yoshiya I. Plasma lipid peroxides and alpha-tocopherol in critically ill patients. Crit. Care Med. 1984;12(11):957\u2013959.", "ArticleIdList": ["6499481"]}, {"Citation": "Ademowo O.S., Dias H.K.I., Burton D.G.A., Griffiths H.R. Lipid (per) oxidation in mitochondria: an emerging target in the ageing process? Biogerontol. 2017;18(6):859\u2013879.", "ArticleIdList": ["PMC5684309", "28540446"]}, {"Citation": "Hecker L. Mechanisms and consequences of oxidative stress in lung disease: therapeutic implications for an aging populace. Am. J. Physiol. Lung Cell. Mol. Physiol. 2018;314(4):L642\u2013L653.", "ArticleIdList": ["PMC5966777", "29351446"]}, {"Citation": "Yan X., Fu X., Jia Y., et al. Nrf2/Keap1/ARE signaling mediated an antioxidative protection of human placental mesenchymal stem cells of fetal origin in alveolar epithelial cells. Oxid. Med. Cell Longev. 2019;2019:2654910.", "ArticleIdList": ["PMC6537011", "31217836"]}, {"Citation": "Tamura D.Y., Moore E.E., Partrick D.A., Johnson J.L., Offner P.J., Silliman C.C.J.S. Acute hypoxemia in humans enhances the neutrophil inflammatory response. Shock. 2002;17(4):269\u2013273.", "ArticleIdList": ["11954825"]}, {"Citation": "Sarma J.V., Ward P.A. Oxidants and redox signaling in acute lung injury. Compr. Physiol. 2011;1(3):1365\u20131381.", "ArticleIdList": ["23733646"]}, {"Citation": "Chen L., Liu H., Liu W., et al. Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia. Chinese J. Tuberculosis Respirat. Dis. 2020;43:E005. doi: 10.3760/cma.j.issn.1001-0939.2020.0005.", "ArticleIdList": ["10.3760/cma.j.issn.1001-0939.2020.0005", "32026671"]}, {"Citation": "Imai Y., Kuba K., Rao S., et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nat. 2005;436(7047):112\u2013116.", "ArticleIdList": ["PMC7094998", "16001071"]}, {"Citation": "Zhou P., Yang X.-L., Wang X.-G., et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nat. 2020;579:270\u2013273.", "ArticleIdList": ["PMC7095418", "32015507"]}, {"Citation": "Rice G.I., Thomas D.A., Grant P.J., Turner A.J., Hooper N.M. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem. J. 2004;383(Pt 1):45\u201351.", "ArticleIdList": ["PMC1134042", "15283675"]}, {"Citation": "Danilczyk U., Eriksson U., Crackower M.A., Penninger J.M. A story of two ACEs. J. Mol. Med. 2003;81(4):227\u2013234.", "ArticleIdList": ["12700890"]}, {"Citation": "Lely A., Hamming I., van Goor H., Navis G.J. Renal ACE2 expression in human kidney disease. J. Pathol. 2004;204(5):587\u2013593.", "ArticleIdList": ["15538735"]}, {"Citation": "De Farias Lelis D., de Freitas D.F., Machado A.S., Crespo T.S., Santos S.H.S. Angiotensin-(1\u20137), Adipokines and Inflammation. Metabolism: Clin. Exp. 2019;95:36\u201345.", "ArticleIdList": ["30905634"]}, {"Citation": "Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506.", "ArticleIdList": ["PMC7159299", "31986264"]}, {"Citation": "Xu Z., Shi L., Wang Y., et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420\u2013422.", "ArticleIdList": ["PMC7164771", "32085846"]}, {"Citation": "Nehme A., Zouein F.A., Deris Zayeri Z. Zibara KJJocd, disease (2019) An update on the tissue renin angiotensin system and its role in physiology and pathology. J. Cardiovasc. Dev. Dis. 2019;6(2):14.", "ArticleIdList": ["PMC6617132", "30934934"]}, {"Citation": "Rajagopalan S., Kurz S., M\u00fcnzel T., et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 1996;97(8):1916\u20131923.", "ArticleIdList": ["PMC507261", "8621776"]}, {"Citation": "Liu Y., Yang Y., Zhang C., et al. (2020) Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci. China Life Sci. 2020;63(3):364\u2013374.", "ArticleIdList": ["PMC7088566", "32048163"]}, {"Citation": "Kuba K., Imai Y., Rao S., et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus\u2013induced lung injury. Nat. Med. 2005;11(8):875\u2013879.", "ArticleIdList": ["PMC7095783", "16007097"]}, {"Citation": "W\u00f6sten-van Asperen R.M., Lutter R., Specht P.A., et al. Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1\u20137) or an angiotensin II receptor antagonist. J. Pathol. 2011;225(4):618\u2013627.", "ArticleIdList": ["22009550"]}, {"Citation": "Huang K.J., Su I.J., Theron M., et al. An interferon-\u03b3-related cytokine storm in SARS patients. J. Med. Virol. 2005;75(2):185\u2013194.", "ArticleIdList": ["PMC7166886", "15602737"]}, {"Citation": "Jiang Y., Xu J., Zhou C., et al. Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. Am. J. Respir. Crit. Care Med. 2005;171(8):850\u2013857.", "ArticleIdList": ["15657466"]}, {"Citation": "Triantafilou K., Triantafilou M. Ion flux in the lung: virus-induced inflammasome activation. Trends Microbiol. 2014;22(10):580\u2013588.", "ArticleIdList": ["PMC7126464", "24986075"]}, {"Citation": "Mart\u00ednez-S\u00e1nchez G., Schwartz A., Donna V. Potential Cytoprotective Activity of Ozone Therapy in SARS-CoV-2/COVID-19. Antioxidants. 2020;9:389.", "ArticleIdList": ["PMC7278582", "32384798"]}, {"Citation": "Martinon F. Detection of immune danger signals by NALP3. J. Leukoc. Biol. 2008;83(3):507\u2013511.", "ArticleIdList": ["17982111"]}, {"Citation": "Shi C.-S., Nabar N.R., Huang N.-N., Kehrl J.H. SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes. Cell Death Discovery. 2019;5(1):1\u201312.", "ArticleIdList": ["PMC6549181", "31231549"]}, {"Citation": "Fung S.Y., Yuen K.S., Ye Z.W., Chan C.P., Jin D.Y. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses. Emerg. Microbes Infect. 2020;9(1):558\u2013570.", "ArticleIdList": ["PMC7103735", "32172672"]}, {"Citation": "S. Toldo, R. Bussani, V. Nuzzi et al., Inflammasome formation in the lungs of patients with fatal COVID-19, Inflamm. Res. 2020 Oct 20;1-4. doi: 10.1007/s00011-020-01413-2. Online ahead of print.", "ArticleIdList": ["PMC7572246", "33079210"]}, {"Citation": "Parsons P.E., Eisner M.D., Thompson B.T., et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit. Care Med. 2005;33(1):1\u20136.", "ArticleIdList": ["15644641"]}, {"Citation": "Pedersen S.F., Ho Y.C. SARS-CoV-2: a storm is raging. J. Clin. Invest. 2020;130(5):2202\u20132205.", "ArticleIdList": ["PMC7190904", "32217834"]}, {"Citation": "Ye Q., Wang B., Mao J. The pathogenesis and treatment of theCytokine Storm'in COVID-19. J. Infect. 2020;80(6):607\u2013613.", "ArticleIdList": ["PMC7194613", "32283152"]}, {"Citation": "Bogdan C., R\u00f6llinghoff M., Diefenbach A. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr. Opin. Immunol. 2000;12(1):64\u201376.", "ArticleIdList": ["10679404"]}, {"Citation": "Joseph J., Ametepe E.S., Haribabu N., et al. Inhibition of ROS and upregulation of inflammatory cytokines by FoxO3a promotes survival against Salmonella typhimurium. Nat. Commun. 2016;7(1):1\u201314.", "ArticleIdList": ["PMC5023958", "27599659"]}, {"Citation": "Martinon F., Mayor A., Tschopp J. The inflammasomes: guardians of the body. Ann. Rev. Immunol. 2009;27:229\u2013265.", "ArticleIdList": ["19302040"]}, {"Citation": "Mason R.J. Pathogenesis of COVID-19 from a cell biology perspective. In. Eur. Respiratory Soc. 2020;55(4) doi: 10.1183/13993003.00607-2020.", "ArticleIdList": ["10.1183/13993003.00607-2020", "PMC7144260", "32269085"]}, {"Citation": "Sun R., Liu H. Wang XJKJoR (2020) Mediastinal emphysema, giant bulla, and pneumothorax developed during the course of COVID-19 pneumonia. Korean J. Radiol. 2020;21(5):541\u2013544.", "ArticleIdList": ["PMC7183834", "32207255"]}, {"Citation": "Wu C., Chen X., Cai Y., et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Internal Med. 2020;180(7) doi: 10.1001/jamainternmed.2020.0994.", "ArticleIdList": ["10.1001/jamainternmed.2020.0994", "PMC7070509", "32167524"]}, {"Citation": "Gil del Valle L., Gravier Hern\u00e1ndez R., Delgado Roche L., Le\u00f3n Fern\u00e1ndez O.S. Oxidative stress in the aging process: fundamental aspects and new insights. Oxidative Stress: Diagnostics, Prevention, and Therapy Volume 2. ACS Publications. 2015:177\u2013219."}, {"Citation": "Davies K.J. The oxygen paradox, oxidative stress, and ageing. Arch. Biochem. Biophys. 2016;595:28\u201332.", "ArticleIdList": ["PMC4838776", "27095211"]}, {"Citation": "Abouhashem A.S., Singh K., Azzazy H.M., Sen C.K.J.A., Signaling R. Is Low Alveolar Type II Cell SOD3 in the Lungs of Elderly Linked to the Observed Severity of COVID-19? Antioxid. Redox Signal. 2020;33(2):59\u201365.", "ArticleIdList": ["PMC7307702", "32323565"]}, {"Citation": "Muhammad S., Bierhaus A., Schwaninger M. Reactive oxygen species in diabetes-induced vascular damage, stroke, and Alzheimer's disease. J. Alzheimers Dis. 2009;16(4):775\u2013785.", "ArticleIdList": ["19387112"]}, {"Citation": "Droge W. Free radicals in the physiological control of cell function. Physiol. Rev. 2002;82(1):47\u201395.", "ArticleIdList": ["11773609"]}, {"Citation": "Kirkham P.A., Barnes P.J. Oxidative stress in COPD. Chest. 2013;144(1):266\u2013273.", "ArticleIdList": ["23880677"]}, {"Citation": "Atabek M.E., Vatansev H., Erkul I. Oxidative stress in childhood obesity. J. Pediatr. Endocrinol. Metab. 2004;17:1063\u20131068.", "ArticleIdList": ["15379416"]}, {"Citation": "Furukawa S., Fujita T., Shimabukuro M., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 2004;114(12):1752\u20131761.", "ArticleIdList": ["PMC535065", "15599400"]}, {"Citation": "Lau A.T., Wang Y., Chiu J.F. Reactive oxygen species: current knowledge and applications in cancer research and therapeutic. J. Cell. Biochem. 2008;104(2):657\u2013667.", "ArticleIdList": ["18172854"]}, {"Citation": "Renschler M.F. The emerging role of reactive oxygen species in cancer therapy. Eur. J. Cancer. 2004;40(13):1934\u20131940.", "ArticleIdList": ["15315800"]}, {"Citation": "Weinberg F., Chandel N.S. Reactive oxygen species-dependent signaling regulates cancer. Cell. Mol. Life Sci. 2009;66(23):3663\u20133673.", "ArticleIdList": ["19629388"]}, {"Citation": "Papadopulos-Eleopulos E. Reappraisal of AIDS\u2014is the oxidation induced by the risk factors the primary cause? Med. Hypotheses. 1988;25:151\u2013162.", "ArticleIdList": ["3285143"]}, {"Citation": "Touyz R.M. Reactive oxygen species and angiotensin II signaling in vascular cells: implications in cardiovascular disease. Braz. J. Med. Biol. Res. 2004;37(8):1263\u20131273.", "ArticleIdList": ["15273829"]}, {"Citation": "Yoshizumi M., Tsuchiya K., Tamaki T. Signal transduction of reactive oxygen species and mitogen-activated protein kinases in cardiovascular. J. Med. Inves. 2001;48(1\u20132):11\u201324.", "ArticleIdList": ["11286012"]}, {"Citation": "Zhou F., Yu T., Du R., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u20131062.", "ArticleIdList": ["PMC7270627", "32171076"]}, {"Citation": "Jordan R.E., Adab P., Cheng K. Covid-19: risk factors for severe disease and death. BMJ. 2020;368 doi: 10.1136/bmj.m1198.", "ArticleIdList": ["10.1136/bmj.m1198", "32217618"]}, {"Citation": "Lighter J., Phillips M., Hochman S., et al. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission. Clin. Infect. Dis. 2020;71(15):896\u2013897.", "ArticleIdList": ["PMC7184372", "32271368"]}, {"Citation": "Violi F., Oliva A., Cangemi R., et al. Nox2 activation in Covid-19. Redox Biol. 2020;36", "ArticleIdList": ["PMC7381406", "32738789"]}, {"Citation": "Lin C.-W., Lin K.-H., Hsieh T.-H., Shiu S.-Y., Li J.-Y.J.F.I., Microbiology M. Severe acute respiratory syndrome coronavirus 3C-like protease-induced apoptosis. FEMS Immunol. Med. Microbiol. 2006;46(3):375\u2013380.", "ArticleIdList": ["PMC7110344", "16553810"]}, {"Citation": "Ul Qamar M.T., Alqahtani S.M., Alamri M.A., Chen L.L. Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J. Pharm. Anal. 2020 Aug;10(4):313\u2013319.", "ArticleIdList": ["PMC7156227", "32296570"]}, {"Citation": "Roche M., Rondeau P., Singh N.R., Tarnus E., Bourdon E. The antioxidant properties of serum albumin. FEBS Lett. 2008;582(13):1783\u20131787.", "ArticleIdList": ["18474236"]}, {"Citation": "Violi F., Ceccarelli G., Cangemi R., et al. Hypoalbuminemia, Coagulopathy and Vascular Disease in Covid-19. Circ. Res. 2020;127(3):400\u2013401.", "ArticleIdList": ["32508261"]}, {"Citation": "Hazucha M.J., Bates D.V., Bromberg P.A. Mechanism of action of ozone on the human lung. J. Appl. Physiol. 1989;67(4):1535\u20131541.", "ArticleIdList": ["2793755"]}, {"Citation": "Bocci V., Borrelli E., Travagli V., Zanardi I. The ozone paradox: ozone is a strong oxidant as well as a medical drug. Med. Res. Rev. 2009;29(4):646\u2013682.", "ArticleIdList": ["19260079"]}, {"Citation": "Bocci V., Zanardi I., Huijberts M.S., Travagli V. Diabetes and chronic oxidative stress. A perspective based on the possible usefulness of ozone therapy. Diabetes Metab. Syndr. 2011;5(1):45\u201349.", "ArticleIdList": ["22814842"]}, {"Citation": "Bocci V. Is it true that ozone is always toxic? The end of a dogma. Toxicol. Appl. Pharmacol. 2006;216(3):493\u2013504.", "ArticleIdList": ["16890971"]}, {"Citation": "Bocci V. The case for oxygen-ozonetherapy. Br. J. Biomed. Sci. 2007;64(1):44\u201349.", "ArticleIdList": ["17444419"]}, {"Citation": "Laubach V.E., Sharma A.K. Mechanisms of lung ischemia-reperfusion injury. Curr. Opin. Organ Transplant. 2016;21(3):246\u2013252.", "ArticleIdList": ["PMC4861054", "26945320"]}, {"Citation": "Ferrari R.S., Andrade C.F. Oxidative stress and lung ischemia-reperfusion injury. Oxid. Med. Cell Longev. 2015;2015", "ArticleIdList": ["PMC4487720", "26161240"]}, {"Citation": "Ajamieh H., Men\u00e9ndez S., Mart\u00ednez-S\u00e1nchez G., et al. Effects of ozone oxidative preconditioning on nitric oxide generation and cellular redox balance in a rat model of hepatic ischaemia\u2013reperfusion. Liver Int. 2004;24(1):55\u201362.", "ArticleIdList": ["15102001"]}, {"Citation": "Peralta C., Leon O., Xaus C., et al. Protective effect of ozone treatment on the injury associated with hepatic ischemia-reperfusion: antioxidant-prooxidant balance. Free Radic. Res. 1999;31(3):191\u2013196.", "ArticleIdList": ["10499775"]}, {"Citation": "Gonz\u00e1lez R., Borrego A., Zamora Z., et al. Reversion by ozone treatment of acute nephrotoxicity induced by cisplatin in rats. Mediators Inflamm. 2004;13(5\u20136):307\u2013312.", "ArticleIdList": ["PMC1781579", "15770045"]}, {"Citation": "Kurtoglu T., Durmaz S., Akgullu C., et al. Ozone preconditioning attenuates contrast-induced nephropathy in rats. J. Surg. Res. 2015;195(2):604\u2013611.", "ArticleIdList": ["25770741"]}, {"Citation": "Onal O., Yetisir F., Sarer A., et al. Prophylactic ozone administration reduces intestinal mucosa injury induced by intestinal ischemia-reperfusion in the rat. Mediators Inflamm. 2015;2015", "ArticleIdList": ["PMC4487723", "26161005"]}, {"Citation": "Nasezadeh P., Shahi F., Fridoni M., Seydi E., Izadi M. Salimi AJFRR (2017) Moderate O3/O2 therapy enhances enzymatic and non-enzymatic antioxidant in brain and cochlear that protects noise-induced hearing loss. Free Radic. Res. 2017;51(9\u201310):828\u2013837.", "ArticleIdList": ["29022413"]}, {"Citation": "Kal A., Kal O., Akillioglu I., et al. The protective effect of prophylactic ozone administration against retinal ischemia-reperfusion injury. Cutan. Ocul. Toxicol. 2017;36(1):39\u201347.", "ArticleIdList": ["27028056"]}, {"Citation": "P. Naserzadeh, Z. Jamali, H. Choobineh, M. Izadi, A. Salimi, Induced Mild Oxidative Stress by Ozone/Oxygen Therapy Enhances Therapy Antioxidant Capacities and Protects Testicular Ischemia/Reperfusion Injury in Rats. Res Square. Preprint. Posted 15 Sep, 2019. doi: 10.21203/rs.2.14446/v1."}, {"Citation": "Re L., Mart\u00ednez-S\u00e1nchez G., Bordicchia M., et al. Is ozone pre-conditioning effect linked to Nrf2/EpRE activation pathway in vivo? A preliminary result. Eur. J. Pharmacol. 2014;742:158\u2013162.", "ArticleIdList": ["25218903"]}, {"Citation": "Inal M., Dokumacioglu A., \u00d6zcelik E., Ucar O. The effects of ozone therapy and coenzyme Q 10 combination on oxidative stress markers in healthy subjects. Ir. J. Med. Sci. 2011;180(3):703\u2013707.", "ArticleIdList": ["21258872"]}, {"Citation": "Loprete F, Vaiano F, Valdenassi L. Outpatient evaluation of oxidative stress in subjects undergoing systemic oxygen-ozone therapy. Ozone Therapy 4(1). https://doi.org/10.4081/ozone.2019.8175."}, {"Citation": "Fern\u00e1ndez O.S.L., Viebahn-Haensler R., Cabreja G.L., Espinosa I.S., Matos Y.H., Roche L.D., Santos B.T., Oru G.T., Polo Vega J.C. Medical ozone increases methotrexate clinical response and improves cellular redox balance in patients with rheumatoid arthritis. Eur. J. Pharmacol. 2016;789:313\u2013318.", "ArticleIdList": ["27450487"]}, {"Citation": "Emma B. Treatment of advanced non-small-cell lung cancer with oxygen ozone therapy and mistletoe: an integrative approach. EurJIntegrative Med. 2012;4:130."}, {"Citation": "Mart\u00ednez-S\u00e1nchez G., Delgado-Roche L., D\u00edaz-Batista A., P\u00e9rez-Davison G., Re L. Effects of ozone therapy on haemostatic and oxidative stress index in coronary artery disease. Eur. J. Pharmacol. 2012;691(1\u20133):156\u2013162.", "ArticleIdList": ["22796450"]}, {"Citation": "Hern\u00e1ndez F., Men\u00e9ndez S., Wong R. Decrease of blood cholesterol and stimulation of antioxidative response in cardiopathy patients treated with endovenous ozone therapy. Free Radic. Biol. Med. 1995;19(1):115\u2013119.", "ArticleIdList": ["7635353"]}, {"Citation": "Buyuklu M., Kandemir F.M., Set T., et al. Beneficial effects of ozone therapy on oxidative stress, cardiac functions and clinical findings in patients with heart failure reduced ejection fraction. Cardiovasc. Toxicol. 2017;17(4):426\u2013433.", "ArticleIdList": ["28097518"]}, {"Citation": "Delgado-Roche L., Riera-Romo M., Mesta F., et al. Medical ozone promotes Nrf2 phosphorylation reducing oxidative stress and pro-inflammatory cytokines in multiple sclerosis patients. Eur. J. Pharmacol. 2017;811:148\u2013154.", "ArticleIdList": ["28623000"]}, {"Citation": "Shah MA, Anande LK, Powar A, Captain J, Mk Nair PJMEJoR, Studies H. The Role of Medical Ozone in Improving Antioxidant Status in Multiple Drug-Resistant Tuberculosis Patients: A Quasi-experimental Study. Middle East J. Rehabil. Health Stud. 2019; 6(4):e97125."}, {"Citation": "M.A. Shah, Ozone Therapy in oxidative stress disorders and evaluation of C- reactive proteins [abstract], Proceedings of the 5Th WFOT Meeting; 2016 Nov 18-20; Mumbai, India, J. Ozone Ther. 2018;2(2). doi: 10.7203/jo3t.2.2.2018.11148."}, {"Citation": "Martinez-Sanchez G., Al-Dalain S.M., Menendez S., et al. Therapeutic efficacy of ozone in patients with diabetic foot. Eur. J. Pharmacol. 2005;523(1\u20133):151\u2013161.", "ArticleIdList": ["16198334"]}, {"Citation": "Fernandez O.S.L., Oru G.T., Vega J.C.P., et al. Ozone+ Arthroscopy: Improved Redox Status, Function and Surgical Outcome in Knee Osteoarthritis Patients. Int. J. Innov. Surg. 2020;3(1):1011."}, {"Citation": "Totolici I.P., Pascu A.M., Poroch V., Mosoiu D. The impact of ozone therapy on antioxidant status and quality of life in palliative care-exploratory study. Rev. Chim. 2017;68(10):2416\u20132421."}, {"Citation": "Pecorelli A., Bocci V., Acquaviva A., et al. NRF2 activation is involved in ozonated human serum upregulation of HO-1 in endothelial cells. Toxicol. Appl. Pharmacol. 2013;267(1):30\u201340.", "ArticleIdList": ["23253326"]}, {"Citation": "Gali\u00e8 M., Costanzo M., Nodari A., et al. Mild ozonisation activates antioxidant cell response by the Keap1/Nrf2 dependent pathway. Free Radic. Biol. Med. 2018;124:114\u2013121.", "ArticleIdList": ["29864481"]}, {"Citation": "Natural Holistic Health Care Ozone And UNB Therapy. Available from https://www.naturalholistic.com/ozone-and-unb-therapy (accessed 21 July 2020)."}, {"Citation": "Bocci V.A., Zanardi I., Travagli V. Ozone acting on human blood yields a hormetic dose-response relationship. J. Transl. Med. 2011;9:66.", "ArticleIdList": ["PMC3125221", "21575276"]}, {"Citation": "Wang Z., Zhang A., Meng W., Wang T., Li D., Liu Z., Liu H. Ozone protects the rat lung from ischemia-reperfusion injury by attenuating NLRP3-mediated inflammation, enhancing Nrf2 antioxidant activity and inhibiting apoptosis. Eur. J. Pharmacol. 2018;835:82\u201393.", "ArticleIdList": ["30075224"]}, {"Citation": "Sagai M., Bocci V. Mechanisms of Action Involved in Ozone Therapy: Is healing induced via a mild oxidative stress? Med. Gas Res. 2011;1:29.", "ArticleIdList": ["PMC3298518", "22185664"]}, {"Citation": "Bocci V. How a calculated oxidative stress can yield multiple therapeutic effects. Free Radic. Res. 2012;46(9):1068\u20131075.", "ArticleIdList": ["22583557"]}, {"Citation": "Bocci V., Valacchi G. Nrf2 activation as target to implement therapeutic treatments. Front. Chem. 2015;3:4.", "ArticleIdList": ["PMC4313773", "25699252"]}, {"Citation": "Hayes J.D., Dinkova-Kostova A.T. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem. Sci. 2014;39(4):199\u2013218.", "ArticleIdList": ["24647116"]}, {"Citation": "Tanito M., Agbaga M.P., Anderson R.E. Upregulation of thioredoxin system via Nrf2-antioxidant responsive element pathway in adaptive-retinal neuroprotection in vivo and in vitro. Free Radic. Biol. Med. 2007;42(12):1838\u20131850.", "ArticleIdList": ["17512463"]}, {"Citation": "MacLeod A.K., McMahon M., Plummer S.M., Higgins L.G., Penning T.M., Igarashi K., Hayes J.D. Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds. Carcinogenesis. 2009;30(9):1571\u20131580.", "ArticleIdList": ["PMC3656619", "19608619"]}, {"Citation": "Agyeman A.S., Chaerkady R., Shaw P.G., Davidson N.E., Visvanathan K., Pandey A., Kensler T.W. Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles. Breast Cancer Res. Treat. 2012;132(1):175\u2013187.", "ArticleIdList": ["PMC3564494", "21597922"]}, {"Citation": "Olagnier D., Farahani E., Thyrsted J., et al. SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate. Nat. Commun. 2020;11(1):1\u201312.", "ArticleIdList": ["PMC7532469", "33009401"]}, {"Citation": "Kobayashi E.H., Suzuki T., Funayama R., et al. Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription. Nat. Commun. 2016;7(1):1\u201314.", "ArticleIdList": ["PMC4879264", "27211851"]}, {"Citation": "Rushworth S.A., Zaitseva L., Murray M.Y., Shah N.M., Bowles K.M., MacEwan D.J. The high Nrf2 expression in human acute myeloid leukemia is driven by NF-\u03baB and underlies its chemo-resistance. Blood. 2012;120(26):5188\u20135198.", "ArticleIdList": ["23077289"]}, {"Citation": "Thimmulappa R.K., Lee H., Rangasamy T., Reddy S.P., Yamamoto M., Kensler T.W., Biswal S. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J. Clin. Invest. 2006;116(4):984\u2013995.", "ArticleIdList": ["PMC1421348", "16585964"]}, {"Citation": "Ahmed S.M., Luo L., Namani A., Wang X.J., Tang X. Nrf2 signaling pathway: Pivotal roles in inflammation. Biochim. Biophys. Acta, Mol. Basis Dis. 2017;1863(2):585\u2013597.", "ArticleIdList": ["27825853"]}, {"Citation": "Imai Y., Kuba K., Neely G.G., et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell. 2008;133(2):235\u2013249.", "ArticleIdList": ["PMC7112336", "18423196"]}, {"Citation": "Nomura M., Ma W., Chen N., Bode A.M., Dong Z. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced NF-kappaB activation by tea polyphenols, (-)-epigallocatechin gallate and theaflavins. Carcinogenesis. 2000;21(10):1885\u20131890.", "ArticleIdList": ["11023547"]}, {"Citation": "Schulze-Osthoff K., Bauer M.K., Vogt M., Wesselborg S. Oxidative stress and signal transduction. Int. J. Vitam. Nutr. Res. 1997;67(5):336\u2013342.", "ArticleIdList": ["9350475"]}, {"Citation": "Guo H., Callaway J.B., Ting J.P. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat. Med. 2015;21(7):677\u2013687.", "ArticleIdList": ["PMC4519035", "26121197"]}, {"Citation": "Minutoli L., Antonuccio P., Irrera N., et al. NLRP3 inflammasome involvement in the organ damage and impaired spermatogenesis induced by testicular ischemia and reperfusion in mice. J. Pharmacol. Exp. Ther. 2015;355(3):370\u2013380.", "ArticleIdList": ["26407722"]}, {"Citation": "Yin N., Peng Z., Li B., Xia J., Wang Z., Yuan J., Fang L., Lu X. Isoflurane attenuates lipopolysaccharide-induced acute lung injury by inhibiting ROS-mediated NLRP3 inflammasome activation. Am. J. Transl. Res. 2016;8(5):2033\u20132046.", "ArticleIdList": ["PMC4891417", "27347312"]}, {"Citation": "Dong W., Yang R., Yang J., Yang J., Ding J., Wu H., Zhang J. Resveratrol pretreatment protects rat hearts from ischemia/reperfusion injury partly via a NALP3 inflammasome pathway. Int. J. Clin. Exp. Pathol. 2015;8(8):8731\u20138741.", "ArticleIdList": ["PMC4583849", "26464617"]}, {"Citation": "Franzini M., Valdenassi L., Ricevuti G., Chirumbolo S., Depfenhart M., Bertossi D., Tirelli U. Oxygen-ozone (O2\u2013O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported. Int. Immunopharmacol. 2020;88", "ArticleIdList": ["PMC7414302", "32795898"]}, {"Citation": "A. Hernandez, M. Vinals, A. Pablos et al., Ozone therapy for patients with SARS-COV-2 pneumonia: a single-center prospective cohort study, 2020. Preprint, medRxiv, doi: https://doi.org/10.1101/2020.06.03.20117994."}, {"Citation": "Fern\u00e1ndez-Cuadros M.E., Albaladejo-Flor\u00edn M.J., \u00c1lava-Rabasa S., et al. Effect of Rectal Ozone (O 3) in Severe COVID-19 Pneumonia: Preliminary Results. SN Comprehensive Clin. Med. 2020;2(9):1328\u20131336.", "ArticleIdList": ["PMC7397966", "32838181"]}, {"Citation": "Hern\u00e1ndez A., Vi\u00f1als M., Isidoro T., Vil\u00e1s F. Potential Role of Oxygen-Ozone Therapy in Treatment of COVID-19 Pneumonia. Am. J. Case Rep. 2020;21", "ArticleIdList": ["PMC7476746", "32804917"]}, {"Citation": "Z. Zheng, M. Dong, K. Hu, A preliminary evaluation on the efficacy of ozone therapy in the treatment of COVID-19, J. Med. Virol. 2020 May 21:10.1002/jmv.26040. doi: 10.1002/jmv.26040. Epub ahead of print.", "ArticleIdList": ["PMC7280732", "32437014"]}, {"Citation": "Wu J., Tan C., Yu H., et al. Case Report: Recovery of One Icu-Acquired Covid-19 Patient Via Ozonated Autohemotherapy. SSRN Electron. J. 2020"}, {"Citation": "Wu J., Tan C.S., Yu H., et al. Recovery of Four COVID-19 Patients via Ozonated Autohemotherapy. Innovation (N Y). 2020;1(3)", "ArticleIdList": ["PMC7609231", "33169118"]}, {"Citation": "C. Tascini, G. Sermann, A. Pagotto et al., Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience, Intern. Emerg. Med. 2020 Nov 1:1\u20137. doi: 10.1007/s11739-020-02542-6. Epub ahead of print.", "ArticleIdList": ["PMC7603641", "33131033"]}, {"Citation": "Valdenassi L., Franzini M., Ricevuti G., Rinaldi L., Galoforo A.C., Tirelli U. Potential mechanisms by which the oxygen-ozone (O2\u2013O3) therapy could contribute to the treatment against the coronavirus COVID-19. Eur. Rev. Med. Pharmacol. Sci. 2020;24(8):4059\u20134061.", "ArticleIdList": ["32374009"]}, {"Citation": "Simonetti V., Quagliariello V., Franzini M., Iaffaioli R.V., Maurea N., Valdenassi L. Ozone Exerts Cytoprotective and Anti-Inflammatory Effects in Cardiomyocytes and Skin Fibroblasts after Incubation with Doxorubicin. Evid. Based Complement Alternat. Med. 2019;2019:2169103.", "ArticleIdList": ["PMC6885772", "31827546"]}, {"Citation": "Italian Society of Oxygen Ozone Therapy (SIOOT). A different therapeutic protocol for each of the five different phenotypes. Available from: (last accessed on 30th November 2020)."}, {"Citation": "J.M. Zhang, Y. Penninger, N. Li, A.S. Zhong, Slutsky, Angiotensin-converting en- zyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target, Intensive Care Med. 2020;46 (4):586\u2013590.", "ArticleIdList": ["PMC7079879", "32125455"]}, {"Citation": "Akerstr\u00f6m S., Gunalan V., Keng C.T., Tan Y.J., Mirazimi A. Dual effect of nitric oxide on SARS-CoV replication: viral RNA production and palmitoylation of the Sprotein are affected. Virology. 2009;395(1):1\u20139.", "ArticleIdList": ["PMC7111989", "19800091"]}, {"Citation": "Robba C., Robba C., Battaglini D., Ball L., Patroniti L.N., Loconte M., Brunetti I., Vena A., Giacobbe D., Bassetti M., Rocco P.R.M., Pelosi P. Distinct phenotypes require distinct respiratory management strategies in severe COVID-19. Respir. Physiol. Neurobiol. 2020;279", "ArticleIdList": ["PMC7211757", "32437877"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "10", "Day": "17"}, {"Year": "2020", "Month": "12", "Day": "13"}, {"Year": "2020", "Month": "12", "Day": "14"}, {"Year": "2021", "Month": "1", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "2", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "1", "Day": "21", "Hour": "20", "Minute": "16"}, {"Year": "2020", "Month": "12", "Day": "21"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33476982", "PMC7752030", "10.1016/j.intimp.2020.107307", "S1567-5769(20)33774-7"]}}], "PubmedBookArticle": []}